1. Home
  2. IOVA vs PCT Comparison

IOVA vs PCT Comparison

Compare IOVA & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$7.03

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$6.88

Market Cap

1.4B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
PCT
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
IOVA
PCT
Price
$7.03
$6.88
Analyst Decision
Buy
Buy
Analyst Count
10
3
Target Price
$9.00
$13.00
AVG Volume (30 Days)
17.2M
4.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
14.84
30.86
EPS
N/A
N/A
Revenue
N/A
$8,355,000.00
Revenue This Year
$47.74
$380.44
Revenue Next Year
$40.31
$203.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$4.93
52 Week High
$7.25
$15.49

Technical Indicators

Market Signals
Indicator
IOVA
PCT
Relative Strength Index (RSI) 71.00 47.72
Support Level $3.57 $5.02
Resistance Level N/A $9.56
Average True Range (ATR) 0.47 0.50
MACD 0.17 0.11
Stochastic Oscillator 89.70 48.23

Price Performance

Historical Comparison
IOVA
PCT

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Share on Social Networks: